BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38002025)

  • 61. S100A4 accelerates the proliferation and invasion of endometrioid carcinoma and is associated with the "MELF" pattern.
    Tahara S; Nojima S; Ohshima K; Hori Y; Kurashige M; Wada N; Ikeda J; Morii E
    Cancer Sci; 2016 Sep; 107(9):1345-52. PubMed ID: 27348205
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Expression of cell cycle regulatory proteins in endometrial adenocarcinoma: variations in conventional tumor areas and in microcystic, elongated and fragmented glands.
    Stewart CJ; Crook ML; Leung YC; Platten M
    Mod Pathol; 2009 May; 22(5):725-33. PubMed ID: 19270644
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Tumoral Morphologic Features From Cervical Biopsies That Are Predictive of a Negligible Risk for Nodal Metastasis and Tumor Recurrence in Usual-type Cervical Adenocarcinomas: A Multi-institutional Study.
    Wang Y; Chang RJ; Luo RZ; Yu J; Zhang X; Yang X; Quddus MR; Li L; Yang W; Liu A; Jiang Q; Zhao R; Zhu H; Zhou F; Wang Y; Sheng X; Liu LL; Wen YL; Banet N; Sung CJ; Qi Y; Bi R; Li M; Wang Y; Li J; Lin W; Wang Y; Rivera G; Chen H; Holloway SB; Fadare O; Liu J; Wang J; Lea J; Kong B; Zheng W
    Am J Surg Pathol; 2022 May; 46(5):713-724. PubMed ID: 34753864
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cytokeratin 19 expression in normal endometrium and in low-grade endometrioid adenocarcinoma of the endometrium.
    Stewart CJ; Crook ML; Lacey J; Louwen K
    Int J Gynecol Pathol; 2011 Sep; 30(5):484-91. PubMed ID: 21804393
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Endocervical Adenocarcinoma: Comprehensive Histological Review and Re-classification of 123 Consecutive Cases According to the Updated World Health Organization Classification of Female Genital Tumors.
    Lee Y; Bae H; Kim HS
    Anticancer Res; 2022 Sep; 42(9):4627-4639. PubMed ID: 36039458
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Micro-anatomical variation in cellular proliferation in endometrial adenocarcinoma, and inverse correlation between Ki67 and cytokeratin 7 expression.
    Stewart CJ; Crook ML; Doherty DA
    Histopathology; 2010 Jul; 57(1):46-54. PubMed ID: 20557372
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Risk Factors Affecting Clinical Outcomes of Low-risk Early-stage Human Papillomavirus-Associated Endocervical Adenocarcinoma Treated by Surgery Alone: Application of Silva Pattern.
    Bae BK; Bae H; Cho WK; Kim BG; Choi CH; Kim TJ; Lee YY; Lee JW; Kim HS; Park W
    Int J Gynecol Pathol; 2024 Jan; ():. PubMed ID: 38294049
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinicopathological significance and prognostic value of myoinvasive patterns in endometrial endometrioid carcinoma.
    Amălinei C; Aignătoaei AM; Balan RA; Giuşcă SE; Lozneanu L; Avădănei ER; Căruntu ID
    Rom J Morphol Embryol; 2018; 59(1):13-22. PubMed ID: 29940607
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Histological features associated with occult lymph node metastasis in FIGO clinical stage I, grade I endometrioid carcinoma.
    Han G; Lim D; Leitao MM; Abu-Rustum NR; Soslow RA
    Histopathology; 2014 Feb; 64(3):389-98. PubMed ID: 24215212
    [TBL] [Abstract][Full Text] [Related]  

  • 70. How to approach the many faces of endometrioid carcinoma.
    Malpica A
    Mod Pathol; 2016 Jan; 29 Suppl 1():S29-44. PubMed ID: 26715172
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Endometrial carcinomas with dyshesive, eosinophilic, and vacuolated (histiocyte-like) tumor cells: a reactive-like phenotype associated with aggressive behavior.
    Travaglino A; Arciuolo D; Raffone A; Santoro A; Piermattei A; Navarra E; Minucci A; Mascolo M; Scaglione G; D'alessandris N; Valente M; Inzani F; Mollo A; Insabato L; Zannoni GF
    Virchows Arch; 2023 Mar; 482(3):635-640. PubMed ID: 36205778
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Disseminated tumor cells are not associated with established risk factors, L1CAM immunoreactivity and outcome in endometrial carcinoma.
    Kommoss S; Hartkopf AD; Krämer B; Bunz AK; Grevenkamp F; Kommoss F; Pasternak J; Arbabi SM; Wallwiener M; Staebler A; Lax SF; Brucker SY; Taran FA
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2183-2188. PubMed ID: 28710714
    [TBL] [Abstract][Full Text] [Related]  

  • 73. FIGO 2018 stage IB endocervical adenocarcinomas: an international study of outcomes informed by prognostic biomarkers.
    Stolnicu S; Boros M; Hoang L; Almadani N; de Brot L; Baiocchi G; Bonvolim G; Parra-Herran C; Lerias S; Felix A; Roma A; Pesci A; Oliva E; Park K; Soslow RA; Abu-Rustum NR
    Int J Gynecol Cancer; 2021 Feb; 31(2):177-184. PubMed ID: 33177150
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prognostic significance of tumor budding, poorly differentiated cluster, and desmoplastic reaction in endometrioid endometrial carcinomas.
    Yamamoto M; Kaizaki Y; Kogami A; Hara T; Sakai Y; Tsuchida T
    J Obstet Gynaecol Res; 2021 Nov; 47(11):3958-3967. PubMed ID: 34448279
    [TBL] [Abstract][Full Text] [Related]  

  • 75. mTOR Pathway Activation Assessed by Immunohistochemistry in Cervical Biopsies of HPV-associated Endocervical Adenocarcinomas (HPVA): Correlation With Silva Invasion Patterns.
    Segura S; Stolnicu S; Boros M; Park K; Ramirez P; Salvo G; Frosina D; Jungbluth A; Soslow RA
    Appl Immunohistochem Mol Morphol; 2021 Aug; 29(7):527-533. PubMed ID: 33587450
    [TBL] [Abstract][Full Text] [Related]  

  • 76. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
    McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
    Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Stromal invasion pattern identifies patients at lowest risk of lymph node metastasis in HPV-associated endocervical adenocarcinomas, but is irrelevant in adenocarcinomas unassociated with HPV.
    Stolnicu S; Barsan I; Hoang L; Patel P; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Oliva E; Park KJ; Abu-Rustum NR; Pike MC; Soslow RA
    Gynecol Oncol; 2018 Jul; 150(1):56-60. PubMed ID: 29859673
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Invasive endocervical adenocarcinoma: proposal for a new pattern-based classification system with significant clinical implications: a multi-institutional study.
    Diaz De Vivar A; Roma AA; Park KJ; Alvarado-Cabrero I; Rasty G; Chanona-Vilchis JG; Mikami Y; Hong SR; Arville B; Teramoto N; Ali-Fehmi R; Rutgers JK; Tabassum F; Barbuto D; Aguilera-Barrantes I; Shaye-Brown A; Daya D; Silva EG
    Int J Gynecol Pathol; 2013 Nov; 32(6):592-601. PubMed ID: 24071876
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Patterns of Invasion of Cervical Adenocarcinoma as Predicators of Outcome.
    Roma AA
    Adv Anat Pathol; 2015 Nov; 22(6):345-54. PubMed ID: 26452210
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Genomic abnormalities in invasive endocervical adenocarcinoma correlate with pattern of invasion: biologic and clinical implications.
    Hodgson A; Amemiya Y; Seth A; Cesari M; Djordjevic B; Parra-Herran C
    Mod Pathol; 2017 Nov; 30(11):1633-1641. PubMed ID: 28731050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.